中文
Products

CK-MB/cTnI/MYO Detection Kit

CK-MB/cTnI/MYO Detection Kit (Quantum Dots-Based Immunofluorescence Chromatography)

Intended Use

For the in vitro quantitative detection of Creatine Kinase-MB / cardiac Troponin I / Myoglobin (CK-MB/cTnI/MYO) in human serum, plasma, or whole.

CK-MB/cTnI/MYO Detection Kit

Clinical Department

Clinical Laboratory, Ambulance/Emergency Department/ICU/Catheterization Laboratory, Cardiology Department/CCU/Thoracic Surgery Department, Respiratory Medicine Department, Geriatrics Department, Physical Examination Center, etc.

Product Parameters Clinical application

[Product Name]CK-MB/cTnI/MYO Detection Kit

[Sample Type]Serum, plasma, and whole blood

[Intended Use]
For the in vitro quantitative detection of Creatine Kinase-MB / cardiac Troponin I / Myoglobin (CK-MB/cTnI/MYO) in human serum, plasma, or whole.

[Clinical Department]
Clinical Laboratory, Ambulance/Emergency Department/ICU/Catheterization Laboratory, Cardiology Department/CCU/Thoracic Surgery Department, Respiratory Medicine Department, Geriatrics Department, Physical Examination Center, etc.

Product Parameters

Item

CK-MB/cTnI/MYO

Test Time

13min

Sample Type

Serum, plasma, and whole blood

Sensitivity

0.1ng/mL; 0.005ng/mL; 1ng/mL

Storage Condition

4-30℃

Packing Specification

Card Type: 25 Tests/Kit, 50 Tests/Kit

Cartridge type: 25 Tests/Kit, 50 Tests/Kit

1. Early diagnosis of Acute Myocardial Infarction (AMI).

2. Prognostic assessment and risk stratification of Acute Coronary Syndrome (ACS).

3. Estimation of myocardial infarction size.

4. Indicator for thrombolytic therapy and interventional treatment after AMI.

5. Detection of the degree of myocardial injury caused by cardiac surgery.

13.jpg

微信公众平台

官网二维码